The story of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in sales , its intellectual property lapse created a wave of knock-off medications, significantly impacting its market share . While specific pharmaceutical companies may try to capitalize on related trea